Theralase Technologies Inc (TLTFF)

[123414]

This technology has superconfined toxity to patient.
Other treatments take so long and must be cycled through the whole body including kidney and lung. Once our immune response is confimeed at 3 month mark each succsesive patient should increace our respone rate.  Which i think will not just be very high but  very high when compared to other treatments respone rates. Therealase is targeting the cancer tumor and remaining cancer after scraping directly.  The one two punch to kill cancer is delivered right at the problem.

Read more at http://www.stockhouse.com/companies/bullboard?symbol=v.tlt&postid=25896220#bHfrCYB0k51WY5tq.99